Comments
Loading...

Stoke Therapeutics

STOKNASDAQ
Logo brought to you by Benzinga Data
$15.14
-0.08-0.53%
At Close: -
$15.12
-0.02-0.13%
After Hours: 4:00 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$50.00
Lowest Price Target1
$12.00
Consensus Price Target1
$24.00

Stoke Therapeutics (NASDAQ:STOK) Stock, Analyst Ratings, Price Targets, Forecasts

Stoke Therapeutics Inc has a consensus price target of $24 based on the ratings of 10 analysts. The high is $50 issued by Jefferies on January 31, 2022. The low is $12 issued by B of A Securities on May 1, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Needham, and Wedbush on September 11, 2024, August 8, 2024, and July 11, 2024, respectively. With an average price target of $24.67 between HC Wainwright & Co., Needham, and Wedbush, there's an implied 63.14% upside for Stoke Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
May
0
0
0
0
Jun
1
Jul
0
0
0
0
Aug
0
0
0
0
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Needham
Wedbush
Canaccord Genuity
JP Morgan

1calculated from analyst ratings

Analyst Ratings for Stoke Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Stoke Therapeutics (STOK) stock?

A

The latest price target for Stoke Therapeutics (NASDAQ:STOK) was reported by HC Wainwright & Co. on September 11, 2024. The analyst firm set a price target for $35.00 expecting STOK to rise to within 12 months (a possible 131.48% upside). 17 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Stoke Therapeutics (STOK)?

A

The latest analyst rating for Stoke Therapeutics (NASDAQ:STOK) was provided by HC Wainwright & Co., and Stoke Therapeutics reiterated their buy rating.

Q

When was the last upgrade for Stoke Therapeutics (STOK)?

A

The last upgrade for Stoke Therapeutics Inc happened on March 26, 2024 when TD Cowen raised their price target to N/A. TD Cowen previously had a hold for Stoke Therapeutics Inc.

Q

When was the last downgrade for Stoke Therapeutics (STOK)?

A

There is no last downgrade for Stoke Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Stoke Therapeutics (STOK)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Stoke Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Stoke Therapeutics was filed on September 11, 2024 so you should expect the next rating to be made available sometime around September 11, 2025.

Q

Is the Analyst Rating Stoke Therapeutics (STOK) correct?

A

While ratings are subjective and will change, the latest Stoke Therapeutics (STOK) rating was a reiterated with a price target of $35.00 to $35.00. The current price Stoke Therapeutics (STOK) is trading at is $15.12, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch